Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Denali Therapeutics Inc shares valued at $247,796 were sold by Ho Carole on Jan 06 ’25. At $20.22 per share, Ho Carole sold 12,255 shares. The insider’s holdings dropped to 178,580 shares worth approximately $2.91 million following the completion of this transaction.
Also, Ho Carole sold 2,907 shares, netting a total of over 60,495 in proceeds. Following the sale of shares at $20.81 each, the insider now holds 175,673 shares.
Before that, Schuth Alexander O. had sold 12,255 shares from its account. In a trade valued at $247,796, the COFO and Secretary traded Denali Therapeutics Inc shares for $20.22 each. Upon closing the transaction, the insider’s holdings decreased to 12,255 shares, worth approximately $4.02 million.
As published in their initiating research note from Deutsche Bank on February 11, 2025, Denali Therapeutics Inc [DNLI] has been a Buy and the price target has been revised to $31. Analysts at Robert W. Baird started covering the stock with ‘”an Outperform”‘ outlook in a report released in early January. As of January 03, 2025, William Blair has initiated its “an Outperform” rating for DNLI. Earlier on December 16, 2024, Stifel upgraded its rating. Their new recommendation was “a Buy” for DNLI stock which previously was a “a Hold”.
Analyzing DNLI Stock Performance
During the last five days, there has been a drop of approximately -12.53%. Over the course of the year, Denali Therapeutics Inc shares have dropped approximately -20.17%. Shares of the company reached a 52-week high of $24.34 on 02/05/25 and a 52-week low of $14.01 on 03/04/25. A 50-day SMA is recorded $20.87, while a 200-day SMA reached $23.63.
Support And Resistance Levels for Denali Therapeutics Inc (DNLI)
According to the 24-hour chart, there is a support level at 15.54, which, if violated, would cause prices to drop to 14.80. In the upper region, resistance lies at 16.68. The next price resistance is at 17.08. RSI (Relative Strength Index) is 30.54 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.78, which suggests the price will decrease in the coming days. Percent R is at 74.32%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
